Oregon 2023 Regular Session

Oregon Senate Bill SB353

Introduced
1/9/23  
Refer
1/12/23  
Refer
4/12/23  
Refer
4/12/23  

Caption

Relating to cannabis; declaring an emergency.

Impact

This legislation is intended to clarify and strengthen the existing legal structure surrounding the cannabis industry within Oregon. By setting clear standards for registration and labeling, SB353 could lead to greater consumer confidence in cannabinoid products. Additionally, it delineates the responsibilities of the Oregon Liquor and Cannabis Commission and reconfirms their authority over issues related to cannabis marketing, which may lead to more consistent enforcement of regulations across the state. The bill also emphasizes the exemption of cannabis seeds from the prohibition on interstate commerce of marijuana items, thereby facilitating the exchange of cannabis seeds between states.

Summary

Senate Bill 353 aims to enhance regulations regarding cannabis and industrial hemp products in Oregon. It mandates the Oregon Liquor and Cannabis Commission to establish a registration program for industrial hemp products that contain cannabinoids intended for human or animal consumption. This includes labeling requirements and the creation of retail sale standards to govern how these hemp products are marketed and sold. The bill is poised to streamline oversight of the cannabis industry in Oregon and ensure that products meet safety and quality standards before reaching consumers.

Sentiment

The sentiment surrounding SB353 appears generally positive among supporters who see it as a necessary step to regulate an evolving industry effectively. There is a sense that establishing rigorous standards will protect consumers and empower the state authority to manage cannabis-related issues efficiently. However, potential opposition may arise from individuals or groups concerned about the implications for small growers and producers, notably regarding the costs associated with compliance and the bureaucratic processes involved in registration.

Contention

Notable points of contention may stem from the bill’s impact on local producers, as stricter registration and labeling requirements could pose challenges for smaller businesses. The requirement for compliance with newly established standards may lead to increased operational costs or regulatory burdens that could disproportionately affect smaller players in the cannabis market. Furthermore, the transfer of oversight for cannabis research from the Oregon Liquor and Cannabis Commission to the Oregon Health Authority might raise questions regarding the focus and direction of cannabis research initiatives in the state.

Companion Bills

No companion bills found.

Similar Bills

OR SB176

Relating to marijuana for medical use; prescribing an effective date.

OR SB1111

Relating to cannabis.

OR HB3214

Relating to marijuana for medical use; prescribing an effective date.

OR SB907

Relating to ownership of premises; and prescribing an effective date.

OR HB3567

Relating to marijuana for medical use; prescribing an effective date.

AZ SB1715

Hemp-derived manufactured impairing cannabinoids

OR HB2515

Relating to cannabis; prescribing an effective date.

OR HB3425

Relating to certified registered nurse anesthetists; and prescribing an effective date.